Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Genetic Screens02:46

Genetic Screens

5.0K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Learning and Machine Learning Modeling Identifies Thidiazuron as a Key Modulator of Somatic Embryogenesis and Shoot Organogenesis in <i>Ferula assa-foetida</i> L.

Biology·2025
Same author

Lightweight Vision Transformer with transfer learning for interpretable Alzheimer's disease severity assessment.

Scientific reports·2025
Same author

Differential Roles of Neuro-Inflammatory Regulator, MAPK11 in Cortex and Hippocampus Following Post-Stroke Cognitive Impairments in Rats.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2025
Same author

Advances in machine intelligence-driven virtual screening approaches for big-data.

Medicinal research reviews·2023
Same author

Evaluation of Electron-Impact Ionization Cross Sections for Molecules.

The journal of physical chemistry. A·2019
Same author

Mechanobiology of Cancer Stem Cells and Their Niche.

Cancer microenvironment : official journal of the International Cancer Microenvironment Society·2019
Same journal

Sampling out-of-distribution chemical spaces via Bayesian flow.

Journal of cheminformatics·2026
Same journal

Hold on tight: the kinetic profiling of opioid receptor ligands using the CORAL-MD.

Journal of cheminformatics·2026
Same journal

Transformer-accelerated discovery of inhibitors targeting the RpsA<sub>Δ438</sub> deletion in PZA-resistant tuberculosis.

Journal of cheminformatics·2026
Same journal

DICL: a manually curated database of ion channels and ligands as a useful platform for drug discovery targeting ion channels.

Journal of cheminformatics·2026
Same journal

DCPM-ADMET: fusion of dual-component pre-trained model and molecular fingerprints to enhance drug ADMET properties prediction.

Journal of cheminformatics·2026
Same journal

Systematic validation of graph neural network explanations against adverse outcome pathway reactive centers for skin sensitization.

Journal of cheminformatics·2026
See all related articles

Related Experiment Video

Updated: Sep 3, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K

Machine intelligence-driven framework for optimized hit selection in virtual screening.

Neeraj Kumar1,2, Vishal Acharya3,4

  • 1Functional Genomics and Complex System Lab, Biotechnology Division,The Himalayan Centre for High-throughput Computational Biology (HiCHiCoB, A BIC Supported by DBT, India), CSIR-Institute of Himalayan Bioresource Technology, Palampur, 176061, Himachal Pradesh, India.

Journal of Cheminformatics
|July 22, 2022
PubMed
Summary
This summary is machine-generated.

The automated hit identification and optimization tool (A-HIOT) improves virtual screening by integrating chemical and protein data, significantly reducing false positives in drug discovery. This framework enhances hit identification and optimization for specific protein targets.

Keywords:
Deep learningInstance-based learningLead optimizationMachine-learningVirtual screening protocol

More Related Videos

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

4.8K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Related Experiment Videos

Last Updated: Sep 3, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

Author Spotlight: High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

4.8K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Bioinformatics and computational biology

Background:

  • Virtual screening (VS) is crucial for identifying potential drug candidates by predicting interactions between compounds and protein targets.
  • Standard VS methods often suffer from high false-positive rates, necessitating improved approaches for hit identification and optimization.
  • Existing ligand-based and structure-based VS methods, while valuable, are often used separately, limiting their combined predictive power.

Purpose of the Study:

  • To introduce an advanced virtual screening framework, the automated hit identification and optimization tool (A-HIOT).
  • To integrate chemical and protein space analyses using machine learning for enhanced prediction accuracy in drug discovery.
  • To provide a robust and generalizable tool for identifying and optimizing selective drug hits for specific protein receptors.

Main Methods:

  • Development of A-HIOT, a framework combining chemical space-driven stacked ensemble for identification and protein space-driven deep learning for optimization.
  • Implementation of numerous open-source algorithms to synergistically integrate chemical and protein data.
  • Rigorous validation using tenfold cross-validation and independent benchmark datasets for targets like CXC chemokine receptor 4 (CXCR4) and androgen receptor (AR).

Main Results:

  • A-HIOT demonstrated superior performance in hit molecule identification and optimization, achieving high accuracies (e.g., 94.8% and 81.9% for CXCR4 via cross-validation).
  • The framework showed high accuracies on independent datasets for CXCR4 (96.2% identification, 89.9% optimization) and AR (86.8% identification, 90.2% optimization).
  • Results indicate A-HIOT's generalizability and robustness across different protein targets.

Conclusions:

  • A-HIOT effectively bridges the gap between ligand-based and structure-based virtual screening.
  • The framework provides a reliable approach for identifying and optimizing selective hits, significantly improving the efficiency of empirical drug discovery.
  • The open-source A-HIOT framework is available, promoting further research and application in the field.